March 19, 2019
A New York federal judge on Tuesday named Kaplan Fox & Kilsheimer LLP lead counsel in a putative class action accusing biopharmaceutical company MiMedx Group Inc. of defrauding investors by concealing a "channel-stuffing" scheme in which the company inflated its earnings by overloading vendors with inventory.